Marimed (MRMD) Other Non-Current Liabilities (2011 - 2025)
Marimed's (MRMD) quarterly Other Non-Current Liabilities came in at $100000.0 in Q3 2025, little changed year-on-year from $100000.0 in Q3 2024, and little changed on a QoQ basis from $100000.0 in Q2 2025.
Marimed (MRMD) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
Marimed (MRMD) has 15 years of Other Non-Current Liabilities data on file, last reported at $100000.0 in Q3 2025.
- On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $100000.0 in Q3 2025; TTM through Sep 2025 was $100000.0, a 0.0% change from a year earlier, with the FY2024 full-year figure at $100000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities for Q3 2025 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for MRMD reached as high as $100200.0 in Q1 2021 and fell as low as $100000.0 in Q4 2021.
- Historically, Other Non-Current Liabilities has averaged $100031.6 across 5 years, with a median of $100000.0 in 2021.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 0.0% in 2021 and fell as far as 0.2% in 2021.
- Year by year, Other Non-Current Liabilities stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $100000.0 in Q3 2025, $100000.0 in Q2 2025, and $100000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,200.00 |
| Jun 30, 2021 | 100,200.00 |
| Mar 31, 2021 | 100,200.00 |
| Dec 31, 2020 | 100,200.00 |